14-day Premium Trial Subscription Try For FreeTry Free
kr3.42
+0.176 (+5.43%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days kr5.34 kr19.02 Friday, 3rd May 2024 CANTA.ST stock ended at kr3.42. This is 5.43% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.83% from a day low at kr3.24 to a day high of kr3.50.
90 days kr17.30 kr19.02
52 weeks kr16.32 kr20.85

Historical Cantargia AB (publ) prices

Date Open High Low Close Volume
May 03, 2024 kr3.24 kr3.50 kr3.24 kr3.42 187 738
May 02, 2024 kr3.34 kr3.48 kr3.20 kr3.24 312 505
Apr 30, 2024 kr3.32 kr3.42 kr3.28 kr3.34 139 309
Apr 29, 2024 kr3.40 kr3.50 kr3.32 kr3.43 159 333
Apr 26, 2024 kr3.47 kr3.49 kr3.32 kr3.45 264 059
Apr 25, 2024 kr3.56 kr3.63 kr3.36 kr3.47 331 410
Apr 24, 2024 kr3.70 kr3.73 kr3.56 kr3.57 285 166
Apr 23, 2024 kr3.73 kr3.81 kr3.59 kr3.70 380 337
Apr 22, 2024 kr3.73 kr3.83 kr3.63 kr3.73 478 715
Apr 19, 2024 kr3.80 kr3.80 kr3.64 kr3.73 267 532
Apr 18, 2024 kr4.02 kr4.05 kr3.76 kr3.80 344 626
Apr 17, 2024 kr3.73 kr3.98 kr3.73 kr3.98 263 248
Apr 16, 2024 kr3.65 kr3.83 kr3.57 kr3.82 364 926
Apr 15, 2024 kr3.90 kr3.96 kr3.60 kr3.65 948 927
Apr 12, 2024 kr4.26 kr4.35 kr3.96 kr4.05 852 742
Apr 11, 2024 kr4.57 kr4.67 kr4.10 kr4.25 1 427 451
Apr 10, 2024 kr4.39 kr4.80 kr4.28 kr4.55 1 399 427
Apr 09, 2024 kr4.28 kr4.38 kr4.13 kr4.35 873 109
Apr 08, 2024 kr4.30 kr4.31 kr4.05 kr4.12 591 888
Apr 05, 2024 kr4.40 kr4.50 kr4.06 kr4.27 1 456 632
Apr 04, 2024 kr4.20 kr4.70 kr3.92 kr4.37 2 868 285
Apr 03, 2024 kr3.88 kr4.26 kr3.78 kr4.15 3 928 881
Apr 02, 2024 kr3.49 kr3.60 kr3.20 kr3.50 1 171 460
Mar 28, 2024 kr3.16 kr3.49 kr3.10 kr3.49 487 264
Mar 27, 2024 kr3.00 kr3.10 kr2.96 kr3.07 403 177
Click to get the best stock tips daily for free!

About Cantargia AB (publ)

Cantargia AB (publ) Cantargia AB (publ), a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. The company is developing CAN04, an antibody against Interleukin-1 Receptor Accessory Protein (IL1RAP) to recognize cancer cells and stimulate natural immune system to destroy such cells, as well as block the tumor inflammation that is driven by the Interleukin-1 system and is under phase IIa clinical t... CANTA.ST Profile

Golden Star

Ticker Date Change Price
TMO May 02 0.403% $571.25
STNG May 02 0.699% $71.50
DLR May 02 2.58% $140.15
RF May 02 0.97% $19.64
INVH May 02 0.87% $34.50
SMAR May 02 2.24% $38.39
BIRK May 02 0.650% $44.61
FTSL May 02 0.217% $46.11
VCSH May 02 0.287% $76.71
VRNT May 02 2.44% $30.78
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT